EVIDENCE LIBRARY
Age and Benzodiazepine Misuse: Motives Should Not Be Assumed From a Drug Result
A lifespan review describes age-related differences in prescription misuse while emphasizing particularly limited benzodiazepine-specific longitudinal evidence.
A lifespan review describes age-related differences in prescription misuse while emphasizing particularly limited benzodiazepine-specific longitudinal evidence.
Patterns in the reviewed literature
Across prescription drug groups, younger populations more often reported peer sources and recreational motives, while older groups more often described physician sources and self-treatment motives. Misuse prevalence generally declined with age. The review included tranquilizers and sedatives, but the evidence for lifespan patterns was strongest for opioids.
Avoid turning patterns into personal assumptions
Much of the literature compared separate samples rather than following the same individuals through aging. Definitions, study periods, and populations varied, and polysubstance use was insufficiently studied. A positive benzodiazepine result cannot establish misuse, motive, source, or dependence. Those require prescription and administration history plus other evidence. The review supports asking age-sensitive questions, not assigning a recreational explanation to every younger person or a therapeutic explanation to every older person. Population tendencies remain uncertain for an individual case.
Source paper
Original analysis of the supplied journal article, identified as PMC7065295.